All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

502

Reset

502 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • TTP399CadisegliatinPhase 32 trials

    vTv Therapeutics · Type 1 Diabetes (T1D), Diabetes Mellitus, Type 1

  • YJ001Phase 32 trials

    Zhejiang Hanmai Pharmaceutical Technology Co., Ltd. · Diabetic Peripheral Neuropathic Pain (DPNP)

  • ZimislecelFormerly known as STx-02, VX-880Phase 32 trials

    Vertex Pharmaceuticals · Type 1 Diabetes, Kidney Transplant, Diabetes Mellitus, Type 1

  • AD-218Phase 31 trial

    Addpharma Inc. · Mixed Dyslipidemia

  • AD-218APhase 31 trial

    Addpharma Inc. · Mixed Dyslipidemia

  • AD-223APhase 31 trial

    Addpharma Inc. · Hypertension,Essential

  • AD-223BPhase 31 trial

    Addpharma Inc. · Hypertension,Essential

  • AD-223CPhase 31 trial

    Addpharma Inc. · Hypertension,Essential

  • AD-224APhase 31 trial

    Addpharma Inc. · Hypertension,Essential

  • AD-224BPhase 31 trial

    Addpharma Inc. · Hypertension,Essential

  • AD-224CPhase 31 trial

    Addpharma Inc. · Hypertension,Essential

  • AD-227APhase 31 trial

    Addpharma Inc. · Essential Hypertension

  • AD-227BPhase 31 trial

    Addpharma Inc. · Essential Hypertension

  • AD-227CPhase 31 trial

    Addpharma Inc. · Essential Hypertension

  • AD-2281Phase 31 trial

    Addpharma Inc. · Primary Hypercholesterolemia

  • AD-2282Phase 31 trial

    Addpharma Inc. · Primary Hypercholesterolemia

  • AD-233APhase 31 trial

    Addpharma Inc. · Type 2 Diabetes Mellitus (T2DM)

  • AD-233BPhase 31 trial

    Addpharma Inc. · Type 2 Diabetes Mellitus (T2DM)

  • AD-233CPhase 31 trial

    Addpharma Inc. · Type 2 Diabetes Mellitus (T2DM)

  • AD-233DPhase 31 trial

    Addpharma Inc. · Type 2 Diabetes Mellitus (T2DM)

  • AG2304RPhase 31 trial

    Ahn-Gook Pharmaceuticals Co.,Ltd · Hypercholesterolemia

  • AG2304TPhase 31 trial

    Ahn-Gook Pharmaceuticals Co.,Ltd · Hypercholesterolemia

  • ATB-1011Phase 31 trial

    Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2

  • ATB-1012Phase 31 trial

    Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2

  • ATB-1013Phase 31 trial

    Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2

  • AVT29proposed aflibercept HD biosimilarPhase 31 trial

    Alvotech Swiss AG · Diabetic Macular Edema

  • BE11164F-PCCPhase 31 trial

    CSL Behring · Complex Cardiovascular Surgery With Cardiopulmonary Bypass

  • BERLIM 2520 ASSOCIATIONPhase 31 trial

    EMS · Dyslipidemia Associated With Type II Diabetes Mellitus

  • BR1018APhase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia

  • BR1018A-1Phase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia

  • BR1018BPhase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia

  • BR1018B-1Phase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia

  • BR1018CPhase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia

  • BR1018C-1Phase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia

  • BR1019APhase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus

  • BR1019A-1Phase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus

  • BR1019BPhase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus

  • BR1019B-1Phase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus

  • BR1019CPhase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus

  • BR1019C-1Phase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus

  • C2402Not ApplicablePhase 31 trial

    JW Pharmaceutical · Hypertension, Dyslipidemia

  • C2403Phase 31 trial

    JW Pharmaceutical · Hypertension, Dyslipidemia

  • C2407Phase 31 trial

    JW Pharmaceutical · Dyslipidemia

  • C52R1LPhase 31 trial

    AJU Pharm Co., Ltd. · Essential Hypertension

  • C52R1MPhase 31 trial

    AJU Pharm Co., Ltd. · Essential Hypertension

  • DA5221-B1Phase 31 trial

    Dong-A ST Co., Ltd. · Type 2 Diabetes

  • DA5221-B2Phase 31 trial

    Dong-A ST Co., Ltd. · Type 2 Diabetes

  • DA5221-T1Phase 31 trial

    Dong-A ST Co., Ltd. · Type 2 Diabetes

  • DA5221-T2Phase 31 trial

    Dong-A ST Co., Ltd. · Type 2 Diabetes

  • DLBS3233InlacinPhase 31 trial

    Dexa Medica Group · Prediabetes

NewerPage 4 of 11Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.